Endotrophin

Endotrophin has been studied in 2 papers since 2021: 2 observational studies in people; 1 in the past year. The newest story, Nov 9, 2026: “Blood hormone adds to heart failure risk prediction in obesity”.

Intervention

2 papers study it2 findingsUpdated

MeSH

1 new paper in 30 daysSee all 2 papers on endotrophin

At a glance

The findings reach cells, none yet in people. 1 lab in 2 countries.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 2 countries
  • Humans2

What did studies of endotrophin find?

2

Studies of endotrophin measured 2 outcomes: insulin-stimulated AKT phosphorylation and fibroinflammation.

Insulin-stimulated AKT phosphorylation

downin human cells1

1 study
  1. Endotrophin decreases insulin-stimulated AKT phosphorylation in human cells (Insulin stimulation).

    “Recombinant ETP increased fibroinflammation and reduced insulin-stimulated AKT phosphorylation cell cultures, reversed by our anti-ETP monoclonal antibody.”

    CellsInsulin stimulationRecombinantLX-2 hepatic stellate cells and HSMM myoblasts

    Blood hormone adds to heart failure risk prediction in obesity

    AHA Scientific Sessions 2026 abstract

More on Insulin-stimulated AKT phosphorylation

Fibroinflammation

upin human cells1

1 study
  1. Endotrophin increases fibroinflammation in human cells.

    “Recombinant ETP increased fibroinflammation and reduced insulin-stimulated AKT phosphorylation cell cultures, reversed by our anti-ETP monoclonal antibody.”

    CellsRecombinantLX-2 hepatic stellate cells and HSMM myoblasts

    Blood hormone adds to heart failure risk prediction in obesity

    AHA Scientific Sessions 2026 abstract

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
AHA Scientific Sessions 2026 Abstract

Blood hormone adds to heart failure risk prediction in obesity

Over 13 years, heart failure developed in 9.69% of adults with obesity in the highest endotrophin group versus 3.12% in the lowest.Over 13 years, heart failure developed in 9.69% of adults with obesity in the highest endotrophin group versus 3.12% in the lowest.

Cohort · 7,728 peopleHeart failure